1. Home
  2. CTKB vs RWAY Comparison

CTKB vs RWAY Comparison

Compare CTKB & RWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • RWAY
  • Stock Information
  • Founded
  • CTKB 1990
  • RWAY 2015
  • Country
  • CTKB United States
  • RWAY United States
  • Employees
  • CTKB N/A
  • RWAY N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • RWAY
  • Sector
  • CTKB Health Care
  • RWAY
  • Exchange
  • CTKB Nasdaq
  • RWAY Nasdaq
  • Market Cap
  • CTKB 430.6M
  • RWAY 410.4M
  • IPO Year
  • CTKB 2021
  • RWAY 2021
  • Fundamental
  • Price
  • CTKB $4.01
  • RWAY $10.88
  • Analyst Decision
  • CTKB Hold
  • RWAY Buy
  • Analyst Count
  • CTKB 4
  • RWAY 6
  • Target Price
  • CTKB $6.00
  • RWAY $11.00
  • AVG Volume (30 Days)
  • CTKB 1.2M
  • RWAY 268.6K
  • Earning Date
  • CTKB 08-06-2025
  • RWAY 08-07-2025
  • Dividend Yield
  • CTKB N/A
  • RWAY 12.87%
  • EPS Growth
  • CTKB N/A
  • RWAY 153.06
  • EPS
  • CTKB N/A
  • RWAY 1.91
  • Revenue
  • CTKB $196,035,000.00
  • RWAY $140,975,000.00
  • Revenue This Year
  • CTKB $0.74
  • RWAY N/A
  • Revenue Next Year
  • CTKB $7.85
  • RWAY N/A
  • P/E Ratio
  • CTKB N/A
  • RWAY $5.68
  • Revenue Growth
  • CTKB N/A
  • RWAY N/A
  • 52 Week Low
  • CTKB $2.37
  • RWAY $8.35
  • 52 Week High
  • CTKB $7.63
  • RWAY $11.73
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 59.09
  • RWAY 51.09
  • Support Level
  • CTKB $3.68
  • RWAY $10.79
  • Resistance Level
  • CTKB $4.19
  • RWAY $11.20
  • Average True Range (ATR)
  • CTKB 0.21
  • RWAY 0.20
  • MACD
  • CTKB 0.02
  • RWAY -0.01
  • Stochastic Oscillator
  • CTKB 76.16
  • RWAY 56.16

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About RWAY Runway Growth Finance Corp.

Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and UK, Canada, Netherlands, with the majority of its portfolio invested in the United States.

Share on Social Networks: